$BIOC BIOCEPT INC Insider Trading
Get free email notifications about insider trading in BIOCEPT INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCEPT INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCEPT INC for free.
IRS Number: 800943522
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Trading Symbol: BIOC
Company Address: 9955 MESA RIM ROAD SAN DIEGO 92121
Phone number: 858-320-8200
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
Market Capitalization: $29.57M
Prev close: $1.57
Average Daily Volume: 2,381,220
Days Low: $1.58
Year Low: $0.74
Year High: $5.64
BIOCEPT INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22 2020 | BIOC | BIOCEPT INC | Riccitelli Samuel D | Director | Option Exercise | A | 4.63 | 10,000 | 46,300 | 10,000 | |
| Oct 22 2020 | BIOC | BIOCEPT INC | Riccitelli Samuel D | Director | Option Exercise | A | 4.63 | 10,000 | 46,300 | 10,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | TERRY MICHAEL J | Sr VP Comm. Operati ... | Option Exercise | A | 4.50 | 48,300 | 217,350 | 48,300 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | Kennedy Timothy | CFO, Sr V.P. Operat ... | Option Exercise | A | 4.50 | 138,000 | 621,000 | 138,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 4.50 | 69,000 | 310,500 | 69,000 | |
| Oct 05 2020 | BIOC | BIOCEPT INC | Nall Michael W. | CEO & President | Option Exercise | A | 4.50 | 241,500 | 1,086,750 | 241,500 | |
| Sep 01 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 0.67 | 54,900 | 36,509 | 54,900 | |
| Sep 01 2020 | BIOC | BIOCEPT INC | DUGAN MICHAEL C | Chief Med Off & Med ... | Option Exercise | A | 0.67 | 54,900 | 36,509 | 54,900 | |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 556 | 309 | 867 | 1.4 K to 867 (-39.07 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.55 | 445 | 247 | 112 | 557 to 112 (-79.89 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
| Jun 12 2020 | BIOC | BIOCEPT INC | HALE DAVID F | Director | Sell | S | 0.56 | 159 | 89 | 3,477 | 3.6 K to 3.5 K (-4.37 %) |
| Jun 09 2020 | BIOC | BIOCEPT INC | Wilson Margaret Faye | Director | Option Exercise | A | 0.48 | 500 | 240 | 500 |